PRTK - Paratek Pharmaceuticals Inc.
Close
2.23
2.230 100.000%
Share volume: 0
Last Updated: Wed 20 Sep 2023 07:59:53 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-04 | 2022-08-03 | 2022-11-03 | 2023-03-16 | 2023-05-09 | 2023-08-03 | |
| Assets | |||||||
| Total Assets | 170.157 M | 163.695 M | 157.321 M | 172.538 M | 150.828 M | 145.792 M | |
| Current Assets | 133.282 M | 127.768 M | 121.341 M | 136.842 M | 111.014 M | 105.227 M | |
| Inventories | 12.732 M | 13.083 M | 20.750 M | 16.565 M | 13.989 M | 11.413 M | |
| Other Current Assets | 12.988 M | 13.476 M | 10.718 M | 7.866 M | 14.708 M | 8.493 M | |
| Short Term Investments | 12.988 M | 13.476 M | 10.718 M | 7.866 M | 14.708 M | 8.493 M | |
| Total Receivables | 28.259 M | 31.818 M | 32.739 M | 78.038 M | 37.166 M | 42.511 M | |
| Current Cash | 79.053 M | 69.391 M | 57.009 M | 34.248 M | 45.026 M | 42.685 M | |
| Total Non-current Assets | 36.875 M | 35.927 M | 35.980 M | 35.696 M | 39.814 M | 40.565 M | |
| Property Plant Equipment | 762.000 K | 712.000 K | 663.000 K | 616.000 K | 601.000 K | 554.000 K | |
| Other Assets | 33.623 M | 32.909 M | 33.360 M | 32.469 M | 36.745 M | 37.537 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 829.000 K | 829.000 K | 829.000 K | 829.000 K | 829.000 K | 829.000 K | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 170.157 M | 163.695 M | 157.321 M | 172.538 M | 150.828 M | 145.792 M | |
| Total liabilities | 310.459 M | 313.062 M | 323.473 M | 343.580 M | 339.866 M | 347.157 M | |
| Total current liabilities | 28.837 M | 30.100 M | 38.976 M | 37.388 M | 32.745 M | 202.619 M | |
| Accounts Payable | 4.697 M | 2.257 M | 8.107 M | 5.308 M | 5.318 M | 2.951 M | |
| Other liabilities | 24.610 M | 24.955 M | 25.394 M | 47.778 M | 48.051 M | 48.824 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 164.042 M | |
| Long term debt | 255.949 M | 257.153 M | 258.482 M | 256.946 M | 257.695 M | 94.285 M | |
| Other liabilities | 24.610 M | 24.955 M | 25.394 M | 47.778 M | 48.051 M | 48.824 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -140.302 M | -149.367 M | -166.152 M | -171.042 M | -189.038 M | -201.365 M | |
| Common stock | 52.150 M | 53.023 M | 55.166 M | 57.212 M | 56.903 M | 57.282 M | |
| Retained earnings | -884.793 M | -902.412 M | -923.292 M | -930.449 M | -950.592 M | -965.145 M |